These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 139203)

  • 21. [Cellular immunity in breast cancer patients].
    Spielmann M; Kitschke HJ; Tietje K
    Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of generation of human cytotoxic effectors by lectins or lectin-activated peripheral blood lymphocytes.
    Mawas C; Charmot D; Comoy A; Sasportes M
    Eur J Immunol; 1977 Jan; 7(1):11-5. PubMed ID: 844478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
    Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
    Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.
    Mukherji B; Nashed AL; Guha A; Ergin MT
    J Immunol; 1986 Mar; 136(5):1893-8. PubMed ID: 2419419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactivity of lymphocytes from draining lymph nodes, peripheral blood and tumor infiltrates from oral cancer patients.
    Mukhopadhyaya R; Tatake RJ; Krishnan N; Rao RS; Fakih AR; Naik SL; Gangal SG
    J Clin Lab Immunol; 1989 Sep; 30(1):21-5. PubMed ID: 2641790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node histology in head and neck cancer: impact of immunotherapy with IRX-2.
    Meneses A; Verastegui E; Barrera JL; de la Garza J; Hadden JW
    Int Immunopharmacol; 2003 Aug; 3(8):1083-91. PubMed ID: 12860165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
    Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
    Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response of regional lymph nodes in patients with lung cancer.
    Ogawa J; Inoue H; Koide S; Kawada S; Shohtsu A
    Tokai J Exp Clin Med; 1981 Jul; 6(3):259-66. PubMed ID: 6975508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-mediated lympholysis in vitro. Independence of mixed lymphocyte reactions and T-cell mitogen responses from the in vitro generation of cytotoxic effectors in primary immunodeficiency diseases.
    Mawas C; Sasportes M; Charmot D; Christen Y; Dausset J
    Clin Exp Immunol; 1975 Apr; 20(1):83-92. PubMed ID: 128428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
    Pak AS; Wright MA; Matthews JP; Collins SL; Petruzzelli GJ; Young MR
    Clin Cancer Res; 1995 Jan; 1(1):95-103. PubMed ID: 9815891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphoid cell subpopulations. I. Synergy between lymph node cells and thymocytes in response to alloantigens and mitogens.
    Howe ML; Cohen L
    J Immunol; 1975 Nov; 115(5):1227-32. PubMed ID: 51885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for head and neck cancer using vaccinia virus expressing IL-2 in a murine model, with evidence of immune suppression.
    Qin H; Valentino J; Manna S; Tripathi PK; Bhattacharya-Chatterjee M; Foon KA; O'Malley BW; Chatterjee SK
    Mol Ther; 2001 Dec; 4(6):551-8. PubMed ID: 11735339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients.
    Catalona WJ; Ratliff TL; McCool RE
    Cancer Res; 1979 Nov; 39(11):4372-7. PubMed ID: 159124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thymosin and irradiation on immune modulation in head and neck and esophageal cancer patients.
    Wara WM; Ammann AJ; Wara DW
    Cancer Treat Rep; 1978 Nov; 62(11):1775-8. PubMed ID: 728896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of T-cell response in autologous mixed lymphocyte-tumor culture by large granular lymphocytes.
    Uchida A; Klein E
    J Natl Cancer Inst; 1986 Mar; 76(3):389-98. PubMed ID: 2419621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1.
    Vose BM
    Arch Geschwulstforsch; 1981; 51(4):317-26. PubMed ID: 6459065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.
    Letessier EM; Sacchi M; Johnson JT; Herberman RB; Whiteside TL
    Cell Immunol; 1990 Oct; 130(2):446-58. PubMed ID: 2145080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma.
    Wang MB; Lichtenstein A; Mickel RA
    Otolaryngol Head Neck Surg; 1991 Oct; 105(4):517-27. PubMed ID: 1762790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.